PARTNER 3 Trial - Mitral Valve in Valve
← catalyst calendarSponsored by Edwards Lifesciences (industry) · EW — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
53actual
Sites
12
Countries
Australia, Brazil, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2018-02-01 | actual | When the study began enrolling |
| Primary completion | 2022-08-16 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2031 | estimated | The whole study's end, after follow-up |
| First posted | 2017-06-21 | actual | When this record first appeared on the registry |
| Results posted | 2023-10-24 | actual | When the sponsor posted results to the registry |
| Record updated | 2025-11-05 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Mitral Valve Insufficiency
- Mitral Valve Disease
- Mitral Valve Regurgitation
- Heart Failure
Intervention
- Device: Edwards SAPIEN 3 transcatheter valve, Model 9600TFX — also filed as TMVR
Primary outcome
what the primary-completion date above is the date OFSafety and Effectiveness - Composite of All-cause Mortality and Stroke
measured 1 Year
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2020-05-08 · 1.0 MB · Prot_SAP_000.pdf
Publications
- PMID 39034924 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · EW's whole pipeline · Catalyst calendar · Every registered study · What changed